search
Back to results

Heliox in Experimental Upper Airway Obstruction

Primary Purpose

Airway Obstruction, Dyspnea

Status
Completed
Phase
Phase 1
Locations
Germany
Study Type
Interventional
Intervention
HELIOX
Sponsored by
University of Witten/Herdecke
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Airway Obstruction focused on measuring Airway obstruction, Heliox, Different Helium content

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Volunteers of both sexes were recruited via posting in student forum of University of Witten/Herdecke
  • Willingness to spend about 2h in the clinical exp. lab.

Exclusion Criteria:

  • Acute airway infection
  • History of asthma
  • Smokers
  • Pregnancy
  • Abnormal lab. screen with liver function tests, Creat./BUN, CBC, blood glucose
  • Anxiety or mood disorder
  • Any chronic disease (incl. lung & heart disease, cancer, endocrine disorder)
  • Mental retardation

Sites / Locations

  • HELIOS-Klinikum / University of Witten/Herdecke

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

1

2

3

Arm Description

Study subjects where breathing Heliox with a fraction of Helium of 25% followed by 50% and 75% with larger external resistor in comparison to medical air

Study subjects where breathing Heliox with a fraction of Helium of 50% followed by 75% and 25% with larger external resistor in comparison to medical air

Study subjects where breathing Heliox with a fraction of Helium of 25% followed by 50% and 75% with larger external resistor in comparison to medical air

Outcomes

Primary Outcome Measures

Dyspnea score
Variability of systolic blood pressure

Secondary Outcome Measures

Full Information

First Posted
November 10, 2008
Last Updated
November 20, 2008
Sponsor
University of Witten/Herdecke
search

1. Study Identification

Unique Protocol Identification Number
NCT00788788
Brief Title
Heliox in Experimental Upper Airway Obstruction
Official Title
PoC Study of Heliox With Helium-Fractions Between 25 and 75% in Experimental Upper Airway Obstruction
Study Type
Interventional

2. Study Status

Record Verification Date
November 2008
Overall Recruitment Status
Completed
Study Start Date
November 2007 (undefined)
Primary Completion Date
December 2007 (Actual)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
University of Witten/Herdecke

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Currently it is common medical wisdom that HELIOX (mixture of Helium in Oxygen) with a fraction of Helium below 60% is not effective in reducing airway obstruction. The investigators test the hypothesis that HELIOX with a fraction of Helium below 60% is still effective in relieving airway obstruction in a double-blind, randomized and controlled clinical PoC study with experimental upper airway obstruction.
Detailed Description
HELIOX is a mixture of Helium and Oxygen. It is a therapeutic modality that can improve upper and lower airway obstruction. The lower density of Helium can help to relieve airway obstruction and is known to lower the work of breathing. The fraction of Helium (FHe) in HELIOX should be maximized (e.g. up to a fraction of 79% with 21% of oxygen added) in order to achieve optimal anti-obstructive outcome and according to the literature a FHe below 60% renders HELIOX ineffective. Objective: We conducted an investigator-initiated trial using different mixtures of Helium and Oxygen in 44 healthy volunteers in a randomized and double-blinded fashion. Methods: After an adjustment phase the subjects were breathing through two different external resistors (intratracheal tube with inner diameter of either 4.0mm or 5.0mm) while gas of different composition (medical air with 79% Nitrogen and 21% Oxygen as control gas and HELIOX with a fraction of either 25%, 50% or 75% Helium in Oxygen, respectively) was provided in a blinded and random fashion. A crossover design was used so that every subject was exposed to every HELIOX gas mixture. Subjects were asked to score their degree of dyspnea after breathing different gas mixtures for 2 minutes intervals. In addition the variability of different hemodynamic parameters was assessed (continuous non-invasive blood pressure (systolic, diastolic and mean blood pressure), impedance cardiography (stroke volume and cardiac output), ECG (heart rate variability)) were assessed non-invasively and used to detected a change in the degree of airway obstruction in respect to the added load and the gas mixture.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Airway Obstruction, Dyspnea
Keywords
Airway obstruction, Heliox, Different Helium content

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
44 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
Study subjects where breathing Heliox with a fraction of Helium of 25% followed by 50% and 75% with larger external resistor in comparison to medical air
Arm Title
2
Arm Type
Active Comparator
Arm Description
Study subjects where breathing Heliox with a fraction of Helium of 50% followed by 75% and 25% with larger external resistor in comparison to medical air
Arm Title
3
Arm Type
Active Comparator
Arm Description
Study subjects where breathing Heliox with a fraction of Helium of 25% followed by 50% and 75% with larger external resistor in comparison to medical air
Intervention Type
Drug
Intervention Name(s)
HELIOX
Intervention Description
HELIOX is a mixture of Helium in Oxygen with a low density and the ability to reduce the work of breathing in subjects with airway obstruction. The fractions of Helium was altered in a different order depending on the arm of the study
Primary Outcome Measure Information:
Title
Dyspnea score
Time Frame
Minutes
Title
Variability of systolic blood pressure
Time Frame
Minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Volunteers of both sexes were recruited via posting in student forum of University of Witten/Herdecke Willingness to spend about 2h in the clinical exp. lab. Exclusion Criteria: Acute airway infection History of asthma Smokers Pregnancy Abnormal lab. screen with liver function tests, Creat./BUN, CBC, blood glucose Anxiety or mood disorder Any chronic disease (incl. lung & heart disease, cancer, endocrine disorder) Mental retardation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hubert Trubel, MD
Organizational Affiliation
University of Witten/Herdecke
Official's Role
Principal Investigator
Facility Information:
Facility Name
HELIOS-Klinikum / University of Witten/Herdecke
City
Wuppertal
State/Province
NRW
ZIP/Postal Code
42283
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
30850876
Citation
Truebel H, Wuester S, Boehme P, Doll H, Schmiedl S, Szymanski J, Langer T, Ostermann T, Cysarz D, Thuermann P. A proof-of-concept trial of HELIOX with different fractions of helium in a human study modeling upper airway obstruction. Eur J Appl Physiol. 2019 May;119(5):1253-1260. doi: 10.1007/s00421-019-04116-7. Epub 2019 Mar 8.
Results Reference
derived

Learn more about this trial

Heliox in Experimental Upper Airway Obstruction

We'll reach out to this number within 24 hrs